Clinical Trial Update: Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects [NA]

View source ↗

Summary

A clinical trial testing a transnasal pulmonary delivery device for COPD and chronic bronchitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: COPD, Chronic Bronchitis | NA | Status: WITHDRAWN